Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Fresh frozen plasma (FFP) is an effective therapy to correct for a deficiency of multiple coagulation factors during bleeding. In past years, use of FFP has increased, in particular in patients on the Intensive Care Unit (ICU), and h...

Full description

Bibliographic Details
Main Authors: Müller Marcella CA, de Jonge Evert, Arbous M Sesmu, Spoelstra -de Man Angelique ME, Karakus Atilla, Vroom Margreeth B, Juffermans Nicole P
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Trials
Subjects:
Online Access:http://www.trialsjournal.com/content/12/1/266
_version_ 1828739653385060352
author Müller Marcella CA
de Jonge Evert
Arbous M Sesmu
Spoelstra -de Man Angelique ME
Karakus Atilla
Vroom Margreeth B
Juffermans Nicole P
author_facet Müller Marcella CA
de Jonge Evert
Arbous M Sesmu
Spoelstra -de Man Angelique ME
Karakus Atilla
Vroom Margreeth B
Juffermans Nicole P
author_sort Müller Marcella CA
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Fresh frozen plasma (FFP) is an effective therapy to correct for a deficiency of multiple coagulation factors during bleeding. In past years, use of FFP has increased, in particular in patients on the Intensive Care Unit (ICU), and has expanded to include prophylactic use in patients with a coagulopathy prior to undergoing an invasive procedure. Retrospective studies suggest that prophylactic use of FFP does not prevent bleeding, but carries the risk of transfusion-related morbidity. However, up to 50% of FFP is administered to non-bleeding ICU patients. With the aim to investigate whether prophylactic FFP transfusions to critically ill patients can be safely omitted, a multi-center randomized clinical trial is conducted in ICU patients with a coagulopathy undergoing an invasive procedure.</p> <p>Methods</p> <p>A non-inferiority, prospective, multicenter randomized open-label, blinded end point evaluation (PROBE) trial. In the intervention group, a prophylactic transfusion of FFP prior to an invasive procedure is omitted compared to transfusion of a fixed dose of 12 ml/kg in the control group. Primary outcome measure is relevant bleeding. Secondary outcome measures are minor bleeding, correction of International Normalized Ratio, onset of acute lung injury, length of ventilation days and length of Intensive Care Unit stay.</p> <p>Discussion</p> <p>The Transfusion of Fresh Frozen Plasma in non-bleeding ICU patients (TOPIC) trial is the first multi-center randomized controlled trial powered to investigate whether it is safe to withhold FFP transfusion to coagulopathic critically ill patients undergoing an invasive procedure.</p> <p>Trial Registration</p> <p>Trial registration: Dutch Trial Register NTR2262 and ClinicalTrials.gov: <a href="http://www.clinicaltrials.gov/ct2/show/NCT01143909">NCT01143909</a></p>
first_indexed 2024-04-13T00:26:11Z
format Article
id doaj.art-e427104e4385493e897b1d03bd1ebede
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-04-13T00:26:11Z
publishDate 2011-12-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-e427104e4385493e897b1d03bd1ebede2022-12-22T03:10:37ZengBMCTrials1745-62152011-12-0112126610.1186/1745-6215-12-266Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trialMüller Marcella CAde Jonge EvertArbous M SesmuSpoelstra -de Man Angelique MEKarakus AtillaVroom Margreeth BJuffermans Nicole P<p>Abstract</p> <p>Background</p> <p>Fresh frozen plasma (FFP) is an effective therapy to correct for a deficiency of multiple coagulation factors during bleeding. In past years, use of FFP has increased, in particular in patients on the Intensive Care Unit (ICU), and has expanded to include prophylactic use in patients with a coagulopathy prior to undergoing an invasive procedure. Retrospective studies suggest that prophylactic use of FFP does not prevent bleeding, but carries the risk of transfusion-related morbidity. However, up to 50% of FFP is administered to non-bleeding ICU patients. With the aim to investigate whether prophylactic FFP transfusions to critically ill patients can be safely omitted, a multi-center randomized clinical trial is conducted in ICU patients with a coagulopathy undergoing an invasive procedure.</p> <p>Methods</p> <p>A non-inferiority, prospective, multicenter randomized open-label, blinded end point evaluation (PROBE) trial. In the intervention group, a prophylactic transfusion of FFP prior to an invasive procedure is omitted compared to transfusion of a fixed dose of 12 ml/kg in the control group. Primary outcome measure is relevant bleeding. Secondary outcome measures are minor bleeding, correction of International Normalized Ratio, onset of acute lung injury, length of ventilation days and length of Intensive Care Unit stay.</p> <p>Discussion</p> <p>The Transfusion of Fresh Frozen Plasma in non-bleeding ICU patients (TOPIC) trial is the first multi-center randomized controlled trial powered to investigate whether it is safe to withhold FFP transfusion to coagulopathic critically ill patients undergoing an invasive procedure.</p> <p>Trial Registration</p> <p>Trial registration: Dutch Trial Register NTR2262 and ClinicalTrials.gov: <a href="http://www.clinicaltrials.gov/ct2/show/NCT01143909">NCT01143909</a></p>http://www.trialsjournal.com/content/12/1/266critically illtransfusionfresh frozen plasmaacute lung injurybleedingrandomized clinical trialTRALIcoagulopathyINRprevention
spellingShingle Müller Marcella CA
de Jonge Evert
Arbous M Sesmu
Spoelstra -de Man Angelique ME
Karakus Atilla
Vroom Margreeth B
Juffermans Nicole P
Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
Trials
critically ill
transfusion
fresh frozen plasma
acute lung injury
bleeding
randomized clinical trial
TRALI
coagulopathy
INR
prevention
title Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
title_full Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
title_fullStr Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
title_full_unstemmed Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
title_short Transfusion of fresh frozen plasma in non-bleeding ICU patients -TOPIC TRIAL: study protocol for a randomized controlled trial
title_sort transfusion of fresh frozen plasma in non bleeding icu patients topic trial study protocol for a randomized controlled trial
topic critically ill
transfusion
fresh frozen plasma
acute lung injury
bleeding
randomized clinical trial
TRALI
coagulopathy
INR
prevention
url http://www.trialsjournal.com/content/12/1/266
work_keys_str_mv AT mullermarcellaca transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT dejongeevert transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT arbousmsesmu transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT spoelstrademanangeliqueme transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT karakusatilla transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT vroommargreethb transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial
AT juffermansnicolep transfusionoffreshfrozenplasmainnonbleedingicupatientstopictrialstudyprotocolforarandomizedcontrolledtrial